Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the condition — or increase the risk of developing it.
On this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager, returns with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton to chat about National Medical Laboratory Professionals Week, April 23–29.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Robert Michel, editor-in-chief of The Dark Report, an intelligence service and publication that provides economic and strategic assessment of the clinical laboratory industry, to provide useful tools for laboratory management.
Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and their variants.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, discuss their leadership roles in national advocacy organizations and the importance of laboratorian engagement in the federal regulatory process.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Beshoi Nashed, a visiting medical student from the Medical University of the Americas in Saint Kitts and Nevis, about his personal perspective on life that has helped him succeed where many others are challenged.
Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC, explain how Mayo Clinic Laboratories' whole genome sequencing provides comprehensive information for rapid diagnosis of hereditary disorders.
Host Bobbi Pritt, M.D., is joined by Robin Patel, M.D., co-director of the Clinical Bacteriology Laboratory at Mayo Clinic and director of the Mayo Clinic Infectious Diseases Research Laboratory, for a discussion on the rising cases and reports of group A streptococcus and antibiotic resistant gonorrhea across the United States.
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor analysis compared with other test methods.
On this episode of Mayo Clinic Laboratories “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, sits down with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton to delve deeper into the world of outreach program management. As true pioneers of the department at Mayo Clinic, Ellen and Brianne share their robust knowledge and experience on the journey to becoming an outreach leader.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Dr. Nour Al-Mozain, a hematopathologist and transfusion medicine consultant at King Faisal Specialist Hospital in Riyadh, Saudi Arabia, about the importance of reaching out to colleagues for advice.
In this episode of “Answers From the Lab,” host and William Morice II, M.D., Ph.D., discuss what’s causing recent outbreaks of norovirus and how to keep yourself protected from this leading cause of foodborne illness in the United States.
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and characterize patients’ marijuana use.